VANFLYTA First FLT3 Inhibitor Approved in the U.S. Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AML Read more
FDA Approves Veklury (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis Read more
Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries Read more
FDA approves expanded indication for Novartis Leqvio (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease Read more
SK bioscience- Government Pharmaceutical Organization Sign Memorandum of Understanding to Strengthen Vaccine Infrastructure in Thailand Read more
Astellas Announces FDA Grants Priority Review for Zolbetuximab Biologics License Application Read more